logo

BUILDPRO vs ENTERO: Stock Comparison

SHANKARA BUILDPRO vs ENTERO HEALTHCARE SOLU LUpdated 19 Oct 26, 4:08 PM ISTNSE & company filings

ENTERO HEALTHCARE SOLU L is the larger company by market capitalisation. SHANKARA BUILDPRO shows a lower P/E, a higher ROE and a higher dividend yield, while ENTERO HEALTHCARE SOLU L shows faster revenue growth and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

BUILDPRO leads 7; ENTERO leads 4 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

BUILDPROENTERO

Valuation lens

What price are you paying?

Market CapContext only
₹2,717 Cr
₹6,558 Cr
P/E RatioBUILDPRO has the lower reading
4.14x ✓
52.28x
P/B RatioBUILDPRO has the lower reading
1x ✓
3.88x
EPSBUILDPRO has the higher reading
₹14.68 ✓
₹8.77
Book ValueContext only
₹225.11
₹402.67
Dividend YieldBUILDPRO has the higher reading
4.46% ✓
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
ENTERO is the larger company
₹6,558 Cr vs ₹2,717 Cr
P/E Ratio
BUILDPRO has a lower P/E
4.14x vs 52.28x
P/B Ratio
BUILDPRO has a lower P/B
1x vs 3.88x
EPS
BUILDPRO has higher earnings per share
₹14.68 vs ₹8.77
Dividend Yield
BUILDPRO has a higher dividend yield
4.46% vs 0%
Revenue Growth (TTM YoY)
ENTERO has faster revenue growth
42.6% vs 0%
EPS Growth (TTM YoY)
ENTERO has faster EPS growth
9.1% vs 0%
ROE
BUILDPRO has a higher ROE
23.39% vs 1.6%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricBUILDPROENTERO
Sector—Consumer Services
Industry—Pharmacy Retail

Price

MetricBUILDPROENTERO
Live Price₹223.2₹1,503.9
Day Change-6.69%-5.12%
Volume3.6 L1.65 L
52-Week High₹1,380₹1,920
52-Week Low₹221.1₹944
Distance from 52W High-83.83%-21.67%

Valuation

MetricBUILDPROENTERO
Market Cap₹2,717 Cr₹6,558 Cr
P/E Ratio4.14x52.28x
P/B Ratio1x3.88x
EPS₹14.68₹8.77
Book Value₹225.11₹402.67
Dividend Yield4.46%0%

Growth

MetricBUILDPROENTERO
Revenue Growth (TTM YoY)0%42.6%
EPS Growth (TTM YoY)0%9.1%
Qtr Sales Growth0%0%
Qtr Profit Growth0%0%

Profitability & Leverage

MetricBUILDPROENTERO
ROE23.39%1.6%
ROCE30.11%2.01%
Net Margin1.87%1.75%
Operating Margin3.16%9.99%
Debt to Equity0.11x0.06x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricBUILDPROENTERO
Promoter Holding40.18%14.4%▼ 0.01 pp
FII Holding7.99%▼ 1.28 pp4.37%▲ 0.34 pp
DII Holding17.37%▲ 3.7 pp15.48%▼ 1.14 pp
Public Holding34.46%▼ 2.43 pp27.75%▲ 0.82 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: SHANKARA BUILDPRO and ENTERO HEALTHCARE SOLU L.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.